Top compounds associated with response to PNPO


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib UHNBreast pan-cancer AAC 0.28 0.3
mRNA YL54 CTRPv2 pan-cancer AAC 0.037 0.4
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.026 0.4
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC 0.041 0.4
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.4
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.049 0.4
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.4
mRNA cediranib CTRPv2 pan-cancer AAC -0.048 0.4
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.041 0.4
mRNA Bax channel blocker CTRPv2 pan-cancer AAC 0.034 0.4
Download CSV